BP targets for kidney disease under revision
BLOOD pressure (BP) targets for patients with chronic kidney disease (CKD) may be revised in line with a review concluding current low targets provide no clinical benefit.
US researchers reviewed three clinical trials of more than 2000 patients with CKD and concluded a BP target of less than 130 mmHg/80 mmHg did not improve clinical outcomes any more than a target of less than 140 mmHg/90 mmHg.
Associate Professor Timothy Mathew, national medical director of Kidney Health Australia, said the report highlighted imperfections in the evidence that led to advice to aim for low BP targets in people with CKD.
“I think this report adds to the case for a revision of these targets,” he said.
He confirmed an updated guideline for managing CKD in general practice would be released in a couple of months but could not confirm whether it would include revised BP targets.
Meanwhile, the review concluded that lower BP targets